Skip to main content

Table 1 Patient characteristics

From: HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia

Patient characteristics

 

Characteristic

(n, %)

Age (years)

58

 <70

40 (69%)

 ≥70

18 (21%)

Sex

58

 Male

44 (76%)

 Female

14 (24%)

WHO classification

58

 RA/RAS

10 (17%)

 RCMD/RSCMD

14 (24%)

 RAEB-I

9 (16%)

 RAEB-II

22 (38%)

 RAEB-t/AML

3 (5%)

WPSS risk group

58

 Very low

6 (10%)

 Low

9 (16%)

 Intermediate

14 (24%)

 High

13 (22%)

 Very high

16 (28%)